Roche launches breast cancer drug Atezolizumab in India - (Outlook India via NewsPoints Desk)

  • Roche has launched the immunotherapy drug atezolizumab for the treatment of metastatic triple-negative breast cancer (TNBC) in India, reported Outlook India.

  • Specifically, the indication is for atezolizumab in combination with nab-paclitaxel as a first-line treatment for TNBC patients.

  • "Atezolizumab is the first immunotherapy drug to be approved globally and in India for TNBC, an aggressive disease with very limited treatment options," said V Simpson Emmanuel, general manager for Roche products in India.

To read more NewsPoints articles, click here.